{"date":"2025-05-21","count":10,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4743-2025-05-21-2041-uceapi","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-05-21","time":"20:41:39","subject":"公告本公司Bonvadis外用乳膏，取得澳洲藥物管理局(TGA)核准完全傷口適應症之醫材上市許可","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-05-21 20:41，「公告本公司Bonvadis外用乳膏，取得澳洲藥物管理局(TGA)核准完全傷口適應症之醫材上市許可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2025-05-21-1908-1p0a6on","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2025-05-21","time":"19:08:36","subject":"本公司新成份新藥AJ201用於治療脊髓和延髓肌肉萎縮症簡稱SBMA或甘迺迪氏症）Phase 1b/2a臨床試驗初步結果","clause":"第8款","fact_date":"2025-05-21","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2025-05-21 19:08，「本公司新成份新藥AJ201用於治療脊髓和延髓肌肉萎縮症簡稱SBMA或甘迺迪氏症）Phase 1b/2a臨床試驗初步結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-05-21-1819-c1638u","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-21","time":"18:19:58","subject":"代子公司共信醫藥科技股份有限公司公告向經濟部智慧財產局提出之專利申請案號數：110143544已獲核准通知","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-05-21 18:19，「代子公司共信醫藥科技股份有限公司公告向經濟部智慧財產局提出之專利申請案號數：110143544已獲核准通知」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-05-21-1747-d9bwy4","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-05-21","time":"17:47:25","subject":"公告本公司114年度股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-05-21 17:47，「公告本公司114年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-05-21-1723-9769qc","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-05-21","time":"17:23:57","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-05-21 17:23，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-05-21-1515-1f3evkt","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-05-21","time":"15:15:07","subject":"代重要子公司Belite Bio, Inc公告LBS-008用於治療斯特格病變新藥獲美國食品藥物管理局(FDA)通知授與「突破性治療認定」(Breakthrough Therapy Designation)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-05-21 15:15，「代重要子公司Belite Bio, Inc公告LBS-008用於治療斯特格病變新藥獲美國食品藥物管理局(FDA)通知授與」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2025-05-21-1452-j8aww1","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2025-05-21","time":"14:52:33","subject":"公告本公司114年除息基準日","clause":"第14款","fact_date":"2025-05-21","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2025-05-21 14:52，「公告本公司114年除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2025-05-21-1450-ds864w","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2025-05-21","time":"14:50:13","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-21","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2025-05-21 14:50，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-05-21-1441-1mohmoc","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-05-21","time":"14:41:19","subject":"代子公司青松長照社團法人公告114年社員總會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-05-21 14:41，「代子公司青松長照社團法人公告114年社員總會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2025-05-21-1416-wxca8k","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2025-05-21","time":"14:16:37","subject":"114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-21","cite_as":"公開資訊觀測站重大訊息：南光（1752），2025-05-21 14:16，「114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}